info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Platelet Aggregation Devices Companies

Platelet aggregation devices are used to assess the ability of platelets in blood to aggregate or clump together. These devices are crucial in studying platelet function, which is essential for understanding hemostasis, thrombosis, and related conditions.

Platelet Aggregation Devices Key CompaniesLatest Platelet Aggregation Devices Companies Update



  • August 2022: OtiTopic, a U.S. respiratory drug development company developing a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction, was acquired by Philip Morris International Inc. If granted approval, the treatment has the potential to rectify the substantial untreated medical condition that affects more than 83 million individuals in the United States who are classified as having an intermediate to high risk for myocardial infarction. By utilizing its inhalation expertise, scientific knowledge, and capabilities to develop a pipeline of inhaled therapeutics and respiratory drug delivery Beyond Nicotine, PMI intends to accomplish this acquisition as part of its strategic plan. After clinical trials conclude and pending U.S. FDA approvals, PMI will be able to bring ASPRIHALE® to market by leveraging its expertise and the capabilities of other companies in the Beyond Nicotine portfolio.



  • RION AESTHETICS, a market leader in regenerative aesthetics, has introduced CALM, an innovative new post-procedure product included in the (plated)â„¢ Skin Science collection, in January 2023. CALM, being the sole skincare product incorporating RenewosomeTM technology, was intentionally formulated to enhance the patient experience in prestigious aesthetic practices while facilitating post-procedure recuperation. In the practices of our partners, the efficacy of the platelet-derived RenewosomeTM technology facilitates a novel strategy for post-procedure recuperation and improves the overall patient experience. CALM is formulated with an exclusive blend of components to aid in recovery and post-procedure care, as well as to improve overall results. The Platelets on Post Procedure Skin (POPPS) Study, which employs CALM subsequent to a CO2 laser procedure, provides support for the launch.


List of Platelet Aggregation Devices Key companies in the market


  • Siemens Healthineers




  • Hoffmann-La Roche Ltd




  • Sentinel CH. SpA




  • Sysmex Corporation




  • Werfen




  • Helena Laboratories




  • Bio/Data Corporation




  • Haemonetics Corporation




  • AggreDyne, Inc.




  • Haemochrom Diagnostica GmbH




  • Pathway Diagnostics Limited



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.